Tilray Brands (TLRY) Cash from Investing Activities Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Tilray Brands | 454.65 Mn | 394.45 Mn | 54.95 Mn | 24,400.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 24,400.00% |
| Nov 30, 2025 | -440.84% |
| Aug 31, 2025 | 149.53% |
| May 31, 2025 | -69.99% |
| Feb 28, 2025 | -100.42% |
| Nov 30, 2024 | -113.16% |
| Aug 31, 2024 | -87.89% |
| May 31, 2024 | 694.09% |
| Feb 29, 2024 | 711.63% |
| Nov 30, 2023 | 130.03% |
| Aug 31, 2023 | -1,610.47% |
| May 31, 2023 | -54.30% |
| Feb 28, 2023 | -347.56% |
| Nov 30, 2022 | -3,792.69% |
| Aug 31, 2022 | 82.17% |
| May 31, 2022 | -101.41% |
| Nov 30, 2021 | 97.52% |
| Aug 31, 2021 | 37.07% |
| May 31, 2021 | 79.16% |
| May 31, 2020 | 340.70% |